Dopamine AntagonistsDopamineReceptors, Dopamine D2Receptors, Dopamine D1Receptors, Dopamine D317-alpha-HydroxypregnenoloneDopamine AgonistsReceptors, DopamineHaloperidolMetoclopramideSpiperoneFlupenthixolBenzazepinesSulpiridePimozideReceptors, Dopamine D4Receptors, Dopamine D5ButaclamolTrifluperidolDopamine AgentsDopamine Plasma Membrane Transport ProteinsBromocriptineFluphenazineButyrophenonesTiapamil HydrochlorideErgotismErgolinesDopamine Uptake InhibitorsQuinpiroleCorpus StriatumRacloprideSalicylamidesAcremoniumAntipsychotic AgentsDopamine beta-HydroxylaseRats, Sprague-DawleyProlactinBehavior, AnimalDose-Response Relationship, DrugNucleus AccumbensApomorphineNeostriatumCocaineAmphetamineDopamine and cAMP-Regulated Phosphoprotein 32Levodopa2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineRats, Inbred StrainsMicrodialysisDopaminergic NeuronsTyrosine 3-MonooxygenaseMotor ActivityHomovanillic AcidNeuronsSubstantia NigraVentral Tegmental AreaTetrahydronaphthalenesOxidopaminePyrrolidinesRadioligand AssayCaudate NucleusCatalepsyBrainMesencephalonPutamenRats, WistarMethamphetamineExcitatory Amino Acid AntagonistsRewardalpha-MethyltyrosineClozapinePiperazinesTropanesDepsipeptidesSerotoninPiperidinesDihydroxyphenylalanineNarcotic AntagonistsHormone AntagonistsDrug InteractionsYawningConditioning, OperantNorepinephrineMuscarinic AntagonistsCoagulaseVesicular Monoamine Transport ProteinsSynaptic TransmissionCentral Nervous System StimulantsBiogenic MonoaminesAnalysis of VarianceBasal GangliaGABA AntagonistsStereotyped BehaviorNicotinic AntagonistsAdenosine A2 Receptor AntagonistsNeurokinin-1 Receptor AntagonistsCocaine-Related DisordersReceptor, Adenosine A2ABinding, CompetitiveTime Factors